2024-10-23 07:32:24
Sciwind Biosciences Announces Positive Interim Results from Ongoing Phase 2b Clinical Trial of XW003 (Ecnoglutide) in Patients with Obesity
Health/ 2023-07-22
Sciwind Biosciences Announces Positive I...

- Mean body weight loss of 11.1% in participants receiving once-weekly injections of 2.4 mg XW003 for 18 weeks

'SWESD 2022,' The Joint World Conference on Social Work, Education and Social Development to be held in Seoul for four days starting 26th Oct.
Health/ 2023-07-22
'SWESD 2022,' The Joint World ...

SEOUL,South Korea,Oct. 26,2022-- "SWESD 2022," The Joint World Conference on Social Work,Education and Social Development will be ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release